NCT05563844 2026-02-04
Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 2 Active not recruiting
Chengdu Zenitar Biomedical Technology Co., Ltd
Masonic Cancer Center, University of Minnesota